Given the intense pharmaceutical and often controversial involvement in the treatment of anaemia in chronic kidney disease, it is surprising that the authors of the reply letter [1] to the criticism of their paper [2] fail to declare the financial support they have received from the relevant companies when they made this declaration in their original publication some months earlier [3].
This omission raises the question of the value of voluntary compliance with conflict of interest declarations when authors fail to comply with the requirements of the conflict of interest form which is very clear, detailed and comprehensive in its format. The omission of conflict of interest declarations in industry sponsored supplements in Nephrology, Dialysis Transplantation is another example of the laxity employed in the observance of full compliance.
Conflict of interest statement. The author is a consultant for Fresenius Medical Care GmBH and Nipro Corporation, Japan.
25 Le Michelangelo 7 Avenue des Papalins Monaco 98000 Email: stanley_shaldon{at}monaco377.com
References